Impact of tailored anti-P2Y12 therapies in acute coronary syndromes

Stimpfle, Fabian; Geisler, Tobias

dc.contributor.author	Stimpfle, Fabian
dc.contributor.author	Geisler, Tobias
dc.date.accessioned	2015-10-08T12:13:21Z
dc.date.available	2015-10-08T12:13:21Z
dc.date.issued	2015
dc.identifier.issn	1462-2416
dc.identifier.uri	http://hdl.handle.net/10900/65401
dc.language.iso	en	en
dc.publisher	Future Medicine Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.2217/PGS.15.19
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Impact of tailored anti-P2Y12 therapies in acute coronary syndromes	de_DE
dc.type	Article	de_DE
utue.quellen.id	20150901145020_02055
utue.publikation.seiten	493-499	de_DE
utue.personen.roh	Stimpfle, Fabian
utue.personen.roh	Geisler, Tobias
dcterms.isPartOf.ZSTitelID	Pharmacogenomics	de_DE
dcterms.isPartOf.ZS-Issue	5	de_DE
dcterms.isPartOf.ZS-Volume	16	de_DE
utue.fakultaet	04 Medizinische Fakultät